舍曲林 (Chinese Wikipedia)

Analysis of information sources in references of the Wikipedia article "舍曲林" in Chinese language version.

refsWebsite

Global rank Chinese rank

47nih.gov

4^th place

5^th place

42doi.org

2^nd place

23^rd place

14web.archive.org

1^st place

12archive.org

6^th place

4^th place

4fda.gov

447^th place

581^st place

4worldcat.org

5^th place

12^th place

2drugs.com

399^th place

208^th place

1psychcentral.com

9,619^th place

low place

1washingtonpost.com

34^th place

129^th place

1medscape.com

719^th place

889^th place

1webcitation.org

24^th place

29^th place

1cpa-apc.org

low place

1abcam.com

low place

1springer.com

274^th place

320^th place

abcam.com

存档副本 (PDF). [2015-09-03]. （原始内容 (PDF)存档于2020-09-20）.

archive.org

Matreja, P. S.; Badyal, D. K.; Khosla, P; Deswal, R. S. Effectiveness and acceptability of sertraline and citalopram in major depressive disorder: pragmatic randomized open-label comparison. Hum Psychopharmacol. 22 October 2007, 22 (7): 477–82. PMID 17647298. doi:10.1002/hup.864.
Parker G, Roy K, Wilhelm K, Mitchell P; Roy; Wilhelm; Mitchell. Assessing the comparative effectiveness of antidepressant therapies: a prospective clinical practice study. J Clin Psychiatry. 2001, 62 (2): 117–25. PMID 11247097. doi:10.4088/JCP.v62n0209.
Papakostas GI, Fava M; Fava. A metaanalysis of clinical trials comparing moclobemide with selective serotonin reuptake inhibitors for the treatment of major depressive disorder. Canadian Journal of Psychiatry. 2006, 51 (12): 783–90. PMID 17168253.
Schneider LS, Nelson JC, Clary CM, Newhouse P, Krishnan KR, Shiovitz T, Weihs K; Nelson; Clary; Newhouse; Krishnan; Shiovitz; Weihs; Sertraline Elderly Depression Study Group. An 8-week multicenter, parallel-group, double-blind, placebo-controlled study of sertraline in elderly outpatients with major depression. Am J Psychiatry. 2003, 160 (7): 1277–85. PMID 12832242. doi:10.1176/appi.ajp.160.7.1277.
Geller DA, Biederman J, Stewart SE, Mullin B, Martin A, Spencer T, Faraone SV; Biederman; Stewart; Mullin; Martin; Spencer; Faraone. Which SSRI? A meta-analysis of pharmacotherapy trials in pediatric obsessive-compulsive disorder. The American Journal of Psychiatry. 2003, 160 (11): 1919–28. PMID 14594734. doi:10.1176/appi.ajp.160.11.1919.
Ackermann RT, Williams JW; Williams Jr. Rational treatment choices for non-major depressions in primary care: an evidence-based review. J Gen Intern Med. 2002, 17 (4): 293–301. PMC 1495030 . PMID 11972726. doi:10.1046/j.1525-1497.2002.10350.x.
Waldinger MD. Premature ejaculation: state of the art. Urol. Clin. North Am. 2007, 34 (4): 591–9, vii–viii. PMID 17983899. doi:10.1016/j.ucl.2007.08.011.
R. Baselt. Disposition of Toxic Drugs and Chemicals in Man 8th. Foster City, California: Biomedical Publications. 2008: 1399–1400.
Taylor, D; Paton, C; Shitij, K. The Maudsley prescribing guidelines in psychiatry. West Sussex: Wiley-Blackwell. 2012. ISBN 978-0-470-97948-8.
Meyer JH, Wilson AA, Sagrati S, Hussey D, Carella A, Potter WZ, Ginovart N, Spencer EP, Cheok A, Houle S; Wilson; Sagrati; Hussey; Carella; Potter; Ginovart; Spencer; Cheok; Houle. Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: an [¹¹C]DASB positron emission tomography study. The American Journal of Psychiatry. 2004, 161 (5): 826–35. PMID 15121647. doi:10.1176/appi.ajp.161.5.826.
Hamelin BA, Turgeon J, Vallée F, Bélanger PM, Paquet F, LeBel M; Turgeon; Vallée; Bélanger; Paquet; Lebel. The disposition of fluoxetine but not sertraline is altered in poor metabolizers of debrisoquin. Clin. Pharmacol. Ther. 1996, 60 (5): 512–21. PMID 8941024. doi:10.1016/S0009-9236(96)90147-2.
Wang JH, Liu ZQ, Wang W, Chen XP, Shu Y, He N, Zhou HH; Liu; Wang; Chen; Shu; He; Zhou. Pharmacokinetics of sertraline in relation to genetic polymorphism of CYP2C19. Clin. Pharmacol. Ther. 2001, 70 (1): 42–7. PMID 11452243. doi:10.1067/mcp.2001.116513.

cpa-apc.org

server03.cpa-apc.org

Blier P, Habib R, Flament MF; Habib; Flament. Pharmacotherapies in the management of obsessive-compulsive disorder (PDF). Can J Psychiatry. 2006, 51 (7): 417–30. PMID 16838823. （原始内容 (PDF)存档于2010-02-04）.

doi.org

Obach RS, Cox LM, Tremaine LM. Sertraline is metabolized by multiple cytochrome P450 enzymes, monoamine oxidases, and glucuronyl transferases in human: an in vitro study. Drug Metab. Dispos. 2005, 33 (2): 262–70. PMID 15547048. doi:10.1124/dmd.104.002428.
Sanchez, C; Reines, E. H.; Montgomery, S. A. A comparative review of escitalopram, paroxetine, and sertraline: are they all alike?. International Clinical Psychopharmacology. 2014, 29 (4): 185–196. PMC 4047306 . PMID 24424469. doi:10.1097/YIC.0000000000000023.
Turner EH, Matthews AM, Linardatos E, Tell RA, Rosenthal R; Matthews; Linardatos; Tell; Rosenthal. Selective publication of antidepressant trials and its influence on apparent efficacy. N. Engl. J. Med. 2008, 358 (3): 252–60. PMID 18199864. doi:10.1056/NEJMsa065779.
Lépine JP, Goger J, Blashko C, Probst C, Moles MF, Kosolowski J, Scharfetter B, Lane RM; Goger; Blashko; Probst; Moles; Kosolowski; Scharfetter; Lane. A double-blind study of the efficacy and safety of sertraline and clomipramine in outpatients with severe major depression. International Clinical Psychopharmacology. 2000, 15 (5): 263–71. PMID 10993128. doi:10.1097/00004850-200015050-00003.
Aberg-Wistedt A, Agren H, Ekselius L, Bengtsson F, Akerblad AC; Agren; Ekselius; Bengtsson; Akerblad. Sertraline versus paroxetine in major depression: clinical outcome after six months of continuous therapy. J Clin Psychopharmacol. 20 December 2000, 20 (6): 645–52. PMID 11106136. doi:10.1097/00004714-200012000-00010.
Ventura D, Armstrong EP, Skrepnek GH, Haim Erder M; Armstrong; Skrepnek; Haim Erder. Escitalopram versus sertraline in the treatment of major depressive disorder: a randomized clinical trial. Current Medical Research and Opinion. 2007, 23 (2): 245–50. PMID 17288677. doi:10.1185/030079906X167273.
Matreja, P. S.; Badyal, D. K.; Khosla, P; Deswal, R. S. Effectiveness and acceptability of sertraline and citalopram in major depressive disorder: pragmatic randomized open-label comparison. Hum Psychopharmacol. 22 October 2007, 22 (7): 477–82. PMID 17647298. doi:10.1002/hup.864.
Flament MF, Lane RM, Zhu R, Ying Z; Lane; Zhu; Ying. Predictors of an acute antidepressant response to fluoxetine and sertraline. Int Clin Psychopharmacol. 1999, 14 (5): 259–75. PMID 10529069. doi:10.1097/00004850-199914050-00001.
Cohen D. Should the use of selective serotonin reuptake inhibitors in child and adolescent depression be banned?. Psychotherapy and psychosomatics. 2007, 76 (1): 5–14. PMID 17170559. doi:10.1159/000096360.
Banerjee S, Hellier J, Romeo R, Dewey M, Knapp M, Ballard C, Baldwin R, Bentham P, Fox C, Holmes C, Katona C, Lawton C, Lindesay J, Livingston G, McCrae N, Moniz-Cook E, Murray J, Nurock S, Orrell M, O'Brien J, Poppe M, Thomas A, Walwyn R, Wilson K, Burns A; Hellier; Romeo; Dewey; Knapp; Ballard; Baldwin; Bentham; Fox; Holmes; Katona; Lawton; Lindesay; Livingston; McCrae; Moniz-Cook; Murray; Nurock; Orrell; O'Brien; Poppe; Thomas; Walwyn; Wilson; Burns. Study of the use of antidepressants for depression in dementia: the HTA-SADD trial – a multicentre, randomised, double-blind, placebo-controlled trial of the clinical effectiveness and cost-effectiveness of sertraline and mirtazapine. Health Technol Assess. 2007, 17 (7): 1–116. PMID 23438937. doi:10.3310/hta17070.
Parker G, Roy K, Wilhelm K, Mitchell P; Roy; Wilhelm; Mitchell. Assessing the comparative effectiveness of antidepressant therapies: a prospective clinical practice study. J Clin Psychiatry. 2001, 62 (2): 117–25. PMID 11247097. doi:10.4088/JCP.v62n0209.
Anderson IM. SSRIS versus tricyclic antidepressants in depressed inpatients: a meta-analysis of efficacy and tolerability. Depress Anxiety. 1998, 7 (S1): 11–7. PMID 9597346. doi:10.1002/(SICI)1520-6394(1998)7:1+<11::AID-DA4>3.0.CO;2-I.
Hirschfeld RM. Efficacy of SSRIs and newer antidepressants in severe depression: comparison with TCAs. J Clin Psychiatry. 1999, 60 (5): 326–35. PMID 10362442. doi:10.4088/JCP.v60n0511.
Amsterdam JD. Selective serotonin reuptake inhibitor efficacy in severe and melancholic depression. J. Psychopharmacol. (Oxford). 1998, 12 (3 Suppl B): S99–111. PMID 9808081. doi:10.1177/0269881198012003061 (不活跃 2015-05-19).
Cipriani A, Furukawa TA, Salanti G, Geddes JR, Higgins JP, Churchill R, Watanabe N, Nakagawa A, Omori IM, McGuire H, Tansella M, Barbui C; Furukawa; Salanti; Geddes; Higgins; Churchill; Watanabe; Nakagawa; Omori; McGuire; Tansella; Barbui. Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. The Lancet. 2009, 373 (9665): 746–758. PMID 19185342. doi:10.1016/S0140-6736(09)60046-5. 简明摘要 – The Washington Post (29 January 2009).
Kavoussi RJ, Segraves RT, Hughes AR, Ascher JA, Johnston JA; Segraves; Hughes; Ascher; Johnston. Double-blind comparison of bupropion sustained release and sertraline in depressed outpatients. The Journal of Clinical Psychiatry. 1997, 58 (12): 532–7. PMID 9448656. doi:10.4088/JCP.v58n1204.
For the review, see:Hansen RA, Gartlehner G, Lohr KN, Gaynes BN, Carey TS; Gartlehner; Lohr; Gaynes; Carey. Efficacy and safety of second-generation antidepressants in the treatment of major depressive disorder. Ann. Intern. Med. 2005, 143 (6): 415–26. PMID 16172440. doi:10.7326/0003-4819-143-6-200509200-00006.
Cipriani, A; La Ferla, T; Furukawa, TA; Signoretti, A; Nakagawa, A; Churchill, R; McGuire, H; Barbui, C. Sertraline versus other antidepressive agents for depression. The Cochrane database of systematic reviews. 14 April 2010, (4): CD006117. PMC 4163971 . PMID 20393946. doi:10.1002/14651858.CD006117.pub4.
Muijsers RB, Plosker GL, Noble S; Plosker; Noble. Sertraline: a review of its use in the management of major depressive disorder in elderly patients. Drugs & Aging. 2002, 19 (5): 377–92. PMID 12093324. doi:10.2165/00002512-200219050-00006.
Schneider LS, Nelson JC, Clary CM, Newhouse P, Krishnan KR, Shiovitz T, Weihs K; Nelson; Clary; Newhouse; Krishnan; Shiovitz; Weihs; Sertraline Elderly Depression Study Group. An 8-week multicenter, parallel-group, double-blind, placebo-controlled study of sertraline in elderly outpatients with major depression. Am J Psychiatry. 2003, 160 (7): 1277–85. PMID 12832242. doi:10.1176/appi.ajp.160.7.1277.
Geller DA, Biederman J, Stewart SE, Mullin B, Martin A, Spencer T, Faraone SV; Biederman; Stewart; Mullin; Martin; Spencer; Faraone. Which SSRI? A meta-analysis of pharmacotherapy trials in pediatric obsessive-compulsive disorder. The American Journal of Psychiatry. 2003, 160 (11): 1919–28. PMID 14594734. doi:10.1176/appi.ajp.160.11.1919.
Pediatric OCD Treatment Study (POTS) Team. Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: the Pediatric OCD Treatment Study (POTS) randomized controlled trial. JAMA. 2004, 292 (16): 1969–76. PMID 15507582. doi:10.1001/jama.292.16.1969.
Sousa MB, Isolan LR, Oliveira RR, Manfro GG, Cordioli AV; Isolan; Oliveira; Manfro; Cordioli. A randomized clinical trial of cognitive-behavioral group therapy and sertraline in the treatment of obsessive-compulsive disorder. The Journal of Clinical Psychiatry. 2006, 67 (7): 1133–9. PMID 16889458. doi:10.4088/JCP.v67n0717.
Jiménez-Jiménez FJ, García-Ruiz PJ; García-Ruiz. Pharmacological options for the treatment of Tourette's disorder. Drugs. 2001, 61 (15): 2207–20. PMID 11772131. doi:10.2165/00003495-200161150-00005.
Hirschfeld RM. Sertraline in the treatment of anxiety disorders. Depress Anxiety. 2000, 11 (4): 139–57. PMID 10945134. doi:10.1002/1520-6394(2000)11:4<139::AID-DA1>3.0.CO;2-C.
Clayton AH, Stewart RS, Fayyad R, Clary CM; Stewart; Fayyad; Clary. Sex differences in clinical presentation and response in panic disorder: pooled data from sertraline treatment studies. Arch Womens Ment Health. 2006, 9 (3): 151–7. PMID 16292466. doi:10.1007/s00737-005-0111-y.
Hansen, Richard A.; Gaynes, Bradley N.; Gartlehner, Gerald; Moore, Charity G.; Tiwari, Ruchi; Lohr, Kathleen N. Efficacy and Tolerability of Second-Generation Antidepressants in Social Anxiety Disorder. International clinical psychopharmacology. 2008-05, 23 (3): 170–179 [2019-03-30]. ISSN 0268-1315. PMC 2657552 . PMID 18408531. doi:10.1097/YIC.0b013e3282f4224a. （原始内容存档于2022-05-04）.
Hansen, Richard A.; Gaynes, Bradley N.; Gartlehner, Gerald; Moore, Charity G.; Tiwari, Ruchi; Lohr, Kathleen N. Efficacy and Tolerability of Second-Generation Antidepressants in Social Anxiety Disorder. International clinical psychopharmacology. 2008-05, 23 (3): 170–179 [2019-03-30]. ISSN 0268-1315. PMC 2657552 . PMID 18408531. doi:10.1097/YIC.0b013e3282f4224a. （原始内容存档于2022-05-04）.
Walkup, John T.; Albano, Anne Marie; Piacentini, John; Birmaher, Boris; Compton, Scott N.; Sherrill, Joel T.; Ginsburg, Golda S.; Rynn, Moira A.; McCracken, James. Cognitive Behavioral Therapy, Sertraline, or a Combination in Childhood Anxiety. The New England journal of medicine. 2008-12-25, 359 (26): 2753–2766 [2019-03-30]. ISSN 0028-4793. PMC 2702984 . PMID 18974308. doi:10.1056/NEJMoa0804633. （原始内容存档于2022-06-22）.
Marjoribanks J, Brown J, O'Brien PM, Wyatt K; Brown; O'Brien; Wyatt. Selective serotonin reuptake inhibitors for premenstrual syndrome. The Cochrane database of systematic reviews. 7 June 2013, 6: CD001396. PMID 23744611. doi:10.1002/14651858.cd001396.pub3.
Pearlstein T. Selective serotonin reuptake inhibitors for premenstrual dysphoric disorder: the emerging gold standard?. Drugs. 2002, 62 (13): 1869–85. PMID 12215058. doi:10.2165/00003495-200262130-00004.
Ackermann RT, Williams JW; Williams Jr. Rational treatment choices for non-major depressions in primary care: an evidence-based review. J Gen Intern Med. 2002, 17 (4): 293–301. PMC 1495030 . PMID 11972726. doi:10.1046/j.1525-1497.2002.10350.x.
Abdel-Hamid IA. Pharmacologic treatment of rapid ejaculation: levels of evidence-based review.. Current clinical pharmacology. September 2006, 1 (3): 243–54. PMID 18666749. doi:10.2174/157488406778249352.
Waldinger MD. Premature ejaculation: state of the art. Urol. Clin. North Am. 2007, 34 (4): 591–9, vii–viii. PMID 17983899. doi:10.1016/j.ucl.2007.08.011.
McMahon CG, Porst H; Porst. Oral agents for the treatment of premature ejaculation: review of efficacy and safety in the context of the recent International Society for Sexual Medicine criteria for lifelong premature ejaculation. The journal of sexual medicine. October 2011, 8 (10): 2707–25. PMID 21771283. doi:10.1111/j.1743-6109.2011.02386.x.
White N, Litovitz T, Clancy C; Litovitz; Clancy. Suicidal antidepressant overdoses: a comparative analysis by antidepressant type. Journal of Medical Toxicology. December 2008, 4 (4): 238–250. PMC 3550116 . PMID 19031375. doi:10.1007/BF03161207/pdf/13181_2009_Article_BF03161207.pdf (不活跃 2015-05-19).
Meyer JH, Wilson AA, Sagrati S, Hussey D, Carella A, Potter WZ, Ginovart N, Spencer EP, Cheok A, Houle S; Wilson; Sagrati; Hussey; Carella; Potter; Ginovart; Spencer; Cheok; Houle. Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: an [¹¹C]DASB positron emission tomography study. The American Journal of Psychiatry. 2004, 161 (5): 826–35. PMID 15121647. doi:10.1176/appi.ajp.161.5.826.
DeVane CL, Liston HL, Markowitz JS; Liston; Markowitz. Clinical pharmacokinetics of sertraline. Clinical Pharmacokinetics. 2002, 41 (15): 1247–66. PMID 12452737. doi:10.2165/00003088-200241150-00002.
Hamelin BA, Turgeon J, Vallée F, Bélanger PM, Paquet F, LeBel M; Turgeon; Vallée; Bélanger; Paquet; Lebel. The disposition of fluoxetine but not sertraline is altered in poor metabolizers of debrisoquin. Clin. Pharmacol. Ther. 1996, 60 (5): 512–21. PMID 8941024. doi:10.1016/S0009-9236(96)90147-2.
Wang JH, Liu ZQ, Wang W, Chen XP, Shu Y, He N, Zhou HH; Liu; Wang; Chen; Shu; He; Zhou. Pharmacokinetics of sertraline in relation to genetic polymorphism of CYP2C19. Clin. Pharmacol. Ther. 2001, 70 (1): 42–7. PMID 11452243. doi:10.1067/mcp.2001.116513.
Madras BK, Fahey MA, Miller GM, De La Garza R, Goulet M, Spealman RD, Meltzer PC, George SR, O'Dowd BF, Bonab AA, Livni E, Fischman AJ; Fahey; Miller; de la Garza; Goulet; Spealman; Meltzer; George; O'Dowd; Bonab; Livni; Fischman. Non-amine-based dopamine transporter (reuptake) inhibitors retain properties of amine-based progenitors. Eur. J. Pharmacol. 2003, 479 (1–3): 41–51. PMID 14612136. doi:10.1016/j.ejphar.2003.08.055.
Ciraulo, DA; Shader, RI (编). Pharmacotherapy of Depression. SpringerLink 2nd (New York, NY: Humana Press). 2011 [2015-10-04]. ISBN 978-1-60327-434-0. doi:10.1007/978-1-60327-435-7. （原始内容存档于2021-02-25）.

drugs.com

drugs.com drugs.com international Sertraline （页面存档备份，存于互联网档案馆） Page accessed May 11, 2015
Sertraline hydrochloride. The American Society of Health-System Pharmacists. [3 April 2011]. （原始内容存档于2016-03-08）.

fda.gov

Sertraline FDA Label. http://www.fda.gov/ohrms/dockets/ac/04/briefing/4006b1_06_zoloft-label.pdf （页面存档备份，存于互联网档案馆）
Levenson M, Holland C. Antidepressants and Suicidality in Adults: Statistical Evaluation. (Presentation at Psychopharmacologic Drugs Advisory Committee; December 13, 2006). FDA. [11 July 2008]. （原始内容存档于2017-05-17）.
Stone MB, Jones ML. Clinical review: relationship between antidepressant drugs and suicidality in adults (PDF). Overview for December 13 Meeting of Psychopharmacologic Drugs Advisory Committee (PDAC). FDA: 11–74. 17 November 2006 [11 July 2008]. （原始内容存档 (PDF)于2007-03-16）.
Levenson M, Holland C. Statistical Evaluation of Suicidality in Adults Treated with Antidepressants (PDF). Overview for December 13 Meeting of Psychopharmacologic Drugs Advisory Committee (PDAC). FDA: 75–140. 17 November 2006 [11 July 2008]. （原始内容存档 (PDF)于2007-03-16）.

medscape.com

Math SB, Janardhan Reddy YC. Issues In The Pharmacological Treatment of Obsessive-Compulsive Disorder: First-Line Treatment Options for OCD. medscape.com. 19 July 2007 [28 July 2009]. （原始内容存档于2021-01-25）.

nih.gov

ncbi.nlm.nih.gov

Obach RS, Cox LM, Tremaine LM. Sertraline is metabolized by multiple cytochrome P450 enzymes, monoamine oxidases, and glucuronyl transferases in human: an in vitro study. Drug Metab. Dispos. 2005, 33 (2): 262–70. PMID 15547048. doi:10.1124/dmd.104.002428.
Sanchez, C; Reines, E. H.; Montgomery, S. A. A comparative review of escitalopram, paroxetine, and sertraline: are they all alike?. International Clinical Psychopharmacology. 2014, 29 (4): 185–196. PMC 4047306 . PMID 24424469. doi:10.1097/YIC.0000000000000023.
Turner EH, Matthews AM, Linardatos E, Tell RA, Rosenthal R; Matthews; Linardatos; Tell; Rosenthal. Selective publication of antidepressant trials and its influence on apparent efficacy. N. Engl. J. Med. 2008, 358 (3): 252–60. PMID 18199864. doi:10.1056/NEJMsa065779.
Lépine JP, Goger J, Blashko C, Probst C, Moles MF, Kosolowski J, Scharfetter B, Lane RM; Goger; Blashko; Probst; Moles; Kosolowski; Scharfetter; Lane. A double-blind study of the efficacy and safety of sertraline and clomipramine in outpatients with severe major depression. International Clinical Psychopharmacology. 2000, 15 (5): 263–71. PMID 10993128. doi:10.1097/00004850-200015050-00003.
Aberg-Wistedt A, Agren H, Ekselius L, Bengtsson F, Akerblad AC; Agren; Ekselius; Bengtsson; Akerblad. Sertraline versus paroxetine in major depression: clinical outcome after six months of continuous therapy. J Clin Psychopharmacol. 20 December 2000, 20 (6): 645–52. PMID 11106136. doi:10.1097/00004714-200012000-00010.
Ventura D, Armstrong EP, Skrepnek GH, Haim Erder M; Armstrong; Skrepnek; Haim Erder. Escitalopram versus sertraline in the treatment of major depressive disorder: a randomized clinical trial. Current Medical Research and Opinion. 2007, 23 (2): 245–50. PMID 17288677. doi:10.1185/030079906X167273.
Matreja, P. S.; Badyal, D. K.; Khosla, P; Deswal, R. S. Effectiveness and acceptability of sertraline and citalopram in major depressive disorder: pragmatic randomized open-label comparison. Hum Psychopharmacol. 22 October 2007, 22 (7): 477–82. PMID 17647298. doi:10.1002/hup.864.
Flament MF, Lane RM, Zhu R, Ying Z; Lane; Zhu; Ying. Predictors of an acute antidepressant response to fluoxetine and sertraline. Int Clin Psychopharmacol. 1999, 14 (5): 259–75. PMID 10529069. doi:10.1097/00004850-199914050-00001.
Cohen D. Should the use of selective serotonin reuptake inhibitors in child and adolescent depression be banned?. Psychotherapy and psychosomatics. 2007, 76 (1): 5–14. PMID 17170559. doi:10.1159/000096360.
Banerjee S, Hellier J, Romeo R, Dewey M, Knapp M, Ballard C, Baldwin R, Bentham P, Fox C, Holmes C, Katona C, Lawton C, Lindesay J, Livingston G, McCrae N, Moniz-Cook E, Murray J, Nurock S, Orrell M, O'Brien J, Poppe M, Thomas A, Walwyn R, Wilson K, Burns A; Hellier; Romeo; Dewey; Knapp; Ballard; Baldwin; Bentham; Fox; Holmes; Katona; Lawton; Lindesay; Livingston; McCrae; Moniz-Cook; Murray; Nurock; Orrell; O'Brien; Poppe; Thomas; Walwyn; Wilson; Burns. Study of the use of antidepressants for depression in dementia: the HTA-SADD trial – a multicentre, randomised, double-blind, placebo-controlled trial of the clinical effectiveness and cost-effectiveness of sertraline and mirtazapine. Health Technol Assess. 2007, 17 (7): 1–116. PMID 23438937. doi:10.3310/hta17070.
Parker G, Roy K, Wilhelm K, Mitchell P; Roy; Wilhelm; Mitchell. Assessing the comparative effectiveness of antidepressant therapies: a prospective clinical practice study. J Clin Psychiatry. 2001, 62 (2): 117–25. PMID 11247097. doi:10.4088/JCP.v62n0209.
Anderson IM. SSRIS versus tricyclic antidepressants in depressed inpatients: a meta-analysis of efficacy and tolerability. Depress Anxiety. 1998, 7 (S1): 11–7. PMID 9597346. doi:10.1002/(SICI)1520-6394(1998)7:1+<11::AID-DA4>3.0.CO;2-I.
Hirschfeld RM. Efficacy of SSRIs and newer antidepressants in severe depression: comparison with TCAs. J Clin Psychiatry. 1999, 60 (5): 326–35. PMID 10362442. doi:10.4088/JCP.v60n0511.
Amsterdam JD. Selective serotonin reuptake inhibitor efficacy in severe and melancholic depression. J. Psychopharmacol. (Oxford). 1998, 12 (3 Suppl B): S99–111. PMID 9808081. doi:10.1177/0269881198012003061 (不活跃 2015-05-19).
Cipriani A, Furukawa TA, Salanti G, Geddes JR, Higgins JP, Churchill R, Watanabe N, Nakagawa A, Omori IM, McGuire H, Tansella M, Barbui C; Furukawa; Salanti; Geddes; Higgins; Churchill; Watanabe; Nakagawa; Omori; McGuire; Tansella; Barbui. Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. The Lancet. 2009, 373 (9665): 746–758. PMID 19185342. doi:10.1016/S0140-6736(09)60046-5. 简明摘要 – The Washington Post (29 January 2009).
Papakostas GI, Fava M; Fava. A metaanalysis of clinical trials comparing moclobemide with selective serotonin reuptake inhibitors for the treatment of major depressive disorder. Canadian Journal of Psychiatry. 2006, 51 (12): 783–90. PMID 17168253.
Feiger A, Kiev A, Shrivastava RK, Wisselink PG, Wilcox CS; Kiev; Shrivastava; Wisselink; Wilcox. Nefazodone versus sertraline in outpatients with major depression: focus on efficacy, tolerability, and effects on sexual function and satisfaction. The Journal of Clinical Psychiatry. 57. 1996,. Suppl 2: 53–62. PMID 8626364.
Kavoussi RJ, Segraves RT, Hughes AR, Ascher JA, Johnston JA; Segraves; Hughes; Ascher; Johnston. Double-blind comparison of bupropion sustained release and sertraline in depressed outpatients. The Journal of Clinical Psychiatry. 1997, 58 (12): 532–7. PMID 9448656. doi:10.4088/JCP.v58n1204.
For the review, see:Hansen RA, Gartlehner G, Lohr KN, Gaynes BN, Carey TS; Gartlehner; Lohr; Gaynes; Carey. Efficacy and safety of second-generation antidepressants in the treatment of major depressive disorder. Ann. Intern. Med. 2005, 143 (6): 415–26. PMID 16172440. doi:10.7326/0003-4819-143-6-200509200-00006.
Cipriani, A; La Ferla, T; Furukawa, TA; Signoretti, A; Nakagawa, A; Churchill, R; McGuire, H; Barbui, C. Sertraline versus other antidepressive agents for depression. The Cochrane database of systematic reviews. 14 April 2010, (4): CD006117. PMC 4163971 . PMID 20393946. doi:10.1002/14651858.CD006117.pub4.
Muijsers RB, Plosker GL, Noble S; Plosker; Noble. Sertraline: a review of its use in the management of major depressive disorder in elderly patients. Drugs & Aging. 2002, 19 (5): 377–92. PMID 12093324. doi:10.2165/00002512-200219050-00006.
Schneider LS, Nelson JC, Clary CM, Newhouse P, Krishnan KR, Shiovitz T, Weihs K; Nelson; Clary; Newhouse; Krishnan; Shiovitz; Weihs; Sertraline Elderly Depression Study Group. An 8-week multicenter, parallel-group, double-blind, placebo-controlled study of sertraline in elderly outpatients with major depression. Am J Psychiatry. 2003, 160 (7): 1277–85. PMID 12832242. doi:10.1176/appi.ajp.160.7.1277.
Geller DA, Biederman J, Stewart SE, Mullin B, Martin A, Spencer T, Faraone SV; Biederman; Stewart; Mullin; Martin; Spencer; Faraone. Which SSRI? A meta-analysis of pharmacotherapy trials in pediatric obsessive-compulsive disorder. The American Journal of Psychiatry. 2003, 160 (11): 1919–28. PMID 14594734. doi:10.1176/appi.ajp.160.11.1919.
Flament MF, Bisserbe JC; Bisserbe. Pharmacologic treatment of obsessive-compulsive disorder: comparative studies. The Journal of Clinical Psychiatry. 58. 1997,. Suppl 12: 18–22. PMID 9393392.
Blier P, Habib R, Flament MF; Habib; Flament. Pharmacotherapies in the management of obsessive-compulsive disorder (PDF). Can J Psychiatry. 2006, 51 (7): 417–30. PMID 16838823. （原始内容 (PDF)存档于2010-02-04）.
Pediatric OCD Treatment Study (POTS) Team. Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: the Pediatric OCD Treatment Study (POTS) randomized controlled trial. JAMA. 2004, 292 (16): 1969–76. PMID 15507582. doi:10.1001/jama.292.16.1969.
Sousa MB, Isolan LR, Oliveira RR, Manfro GG, Cordioli AV; Isolan; Oliveira; Manfro; Cordioli. A randomized clinical trial of cognitive-behavioral group therapy and sertraline in the treatment of obsessive-compulsive disorder. The Journal of Clinical Psychiatry. 2006, 67 (7): 1133–9. PMID 16889458. doi:10.4088/JCP.v67n0717.
Jiménez-Jiménez FJ, García-Ruiz PJ; García-Ruiz. Pharmacological options for the treatment of Tourette's disorder. Drugs. 2001, 61 (15): 2207–20. PMID 11772131. doi:10.2165/00003495-200161150-00005.
Hirschfeld RM. Sertraline in the treatment of anxiety disorders. Depress Anxiety. 2000, 11 (4): 139–57. PMID 10945134. doi:10.1002/1520-6394(2000)11:4<139::AID-DA1>3.0.CO;2-C.
Clayton AH, Stewart RS, Fayyad R, Clary CM; Stewart; Fayyad; Clary. Sex differences in clinical presentation and response in panic disorder: pooled data from sertraline treatment studies. Arch Womens Ment Health. 2006, 9 (3): 151–7. PMID 16292466. doi:10.1007/s00737-005-0111-y.
Hansen, Richard A.; Gaynes, Bradley N.; Gartlehner, Gerald; Moore, Charity G.; Tiwari, Ruchi; Lohr, Kathleen N. Efficacy and Tolerability of Second-Generation Antidepressants in Social Anxiety Disorder. International clinical psychopharmacology. 2008-05, 23 (3): 170–179 [2019-03-30]. ISSN 0268-1315. PMC 2657552 . PMID 18408531. doi:10.1097/YIC.0b013e3282f4224a. （原始内容存档于2022-05-04）.
Hansen, Richard A.; Gaynes, Bradley N.; Gartlehner, Gerald; Moore, Charity G.; Tiwari, Ruchi; Lohr, Kathleen N. Efficacy and Tolerability of Second-Generation Antidepressants in Social Anxiety Disorder. International clinical psychopharmacology. 2008-05, 23 (3): 170–179 [2019-03-30]. ISSN 0268-1315. PMC 2657552 . PMID 18408531. doi:10.1097/YIC.0b013e3282f4224a. （原始内容存档于2022-05-04）.
Walkup, John T.; Albano, Anne Marie; Piacentini, John; Birmaher, Boris; Compton, Scott N.; Sherrill, Joel T.; Ginsburg, Golda S.; Rynn, Moira A.; McCracken, James. Cognitive Behavioral Therapy, Sertraline, or a Combination in Childhood Anxiety. The New England journal of medicine. 2008-12-25, 359 (26): 2753–2766 [2019-03-30]. ISSN 0028-4793. PMC 2702984 . PMID 18974308. doi:10.1056/NEJMoa0804633. （原始内容存档于2022-06-22）.
Gale, Christopher K; Millichamp, Jane. Generalised anxiety disorder. BMJ Clinical Evidence. 2011-10-27, 2011 [2019-03-30]. ISSN 1752-8526. PMC 3275153 . PMID 22030083. （原始内容存档于2022-05-09）.
Marjoribanks J, Brown J, O'Brien PM, Wyatt K; Brown; O'Brien; Wyatt. Selective serotonin reuptake inhibitors for premenstrual syndrome. The Cochrane database of systematic reviews. 7 June 2013, 6: CD001396. PMID 23744611. doi:10.1002/14651858.cd001396.pub3.
Pearlstein T. Selective serotonin reuptake inhibitors for premenstrual dysphoric disorder: the emerging gold standard?. Drugs. 2002, 62 (13): 1869–85. PMID 12215058. doi:10.2165/00003495-200262130-00004.
Ackermann RT, Williams JW; Williams Jr. Rational treatment choices for non-major depressions in primary care: an evidence-based review. J Gen Intern Med. 2002, 17 (4): 293–301. PMC 1495030 . PMID 11972726. doi:10.1046/j.1525-1497.2002.10350.x.
Abdel-Hamid IA. Pharmacologic treatment of rapid ejaculation: levels of evidence-based review.. Current clinical pharmacology. September 2006, 1 (3): 243–54. PMID 18666749. doi:10.2174/157488406778249352.
Waldinger MD. Premature ejaculation: state of the art. Urol. Clin. North Am. 2007, 34 (4): 591–9, vii–viii. PMID 17983899. doi:10.1016/j.ucl.2007.08.011.
McMahon CG, Porst H; Porst. Oral agents for the treatment of premature ejaculation: review of efficacy and safety in the context of the recent International Society for Sexual Medicine criteria for lifelong premature ejaculation. The journal of sexual medicine. October 2011, 8 (10): 2707–25. PMID 21771283. doi:10.1111/j.1743-6109.2011.02386.x.
White N, Litovitz T, Clancy C; Litovitz; Clancy. Suicidal antidepressant overdoses: a comparative analysis by antidepressant type. Journal of Medical Toxicology. December 2008, 4 (4): 238–250. PMC 3550116 . PMID 19031375. doi:10.1007/BF03161207/pdf/13181_2009_Article_BF03161207.pdf (不活跃 2015-05-19).
Meyer JH, Wilson AA, Sagrati S, Hussey D, Carella A, Potter WZ, Ginovart N, Spencer EP, Cheok A, Houle S; Wilson; Sagrati; Hussey; Carella; Potter; Ginovart; Spencer; Cheok; Houle. Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: an [¹¹C]DASB positron emission tomography study. The American Journal of Psychiatry. 2004, 161 (5): 826–35. PMID 15121647. doi:10.1176/appi.ajp.161.5.826.
DeVane CL, Liston HL, Markowitz JS; Liston; Markowitz. Clinical pharmacokinetics of sertraline. Clinical Pharmacokinetics. 2002, 41 (15): 1247–66. PMID 12452737. doi:10.2165/00003088-200241150-00002.
Kobayashi K, Ishizuka T, Shimada N, Yoshimura Y, Kamijima K, Chiba K; Ishizuka; Shimada; Yoshimura; Kamijima; Chiba. Sertraline N-demethylation is catalyzed by multiple isoforms of human cytochrome P-450 in vitro. Drug Metab. Dispos. 1999, 27 (7): 763–6. PMID 10383917.
Hamelin BA, Turgeon J, Vallée F, Bélanger PM, Paquet F, LeBel M; Turgeon; Vallée; Bélanger; Paquet; Lebel. The disposition of fluoxetine but not sertraline is altered in poor metabolizers of debrisoquin. Clin. Pharmacol. Ther. 1996, 60 (5): 512–21. PMID 8941024. doi:10.1016/S0009-9236(96)90147-2.
Wang JH, Liu ZQ, Wang W, Chen XP, Shu Y, He N, Zhou HH; Liu; Wang; Chen; Shu; He; Zhou. Pharmacokinetics of sertraline in relation to genetic polymorphism of CYP2C19. Clin. Pharmacol. Ther. 2001, 70 (1): 42–7. PMID 11452243. doi:10.1067/mcp.2001.116513.
Madras BK, Fahey MA, Miller GM, De La Garza R, Goulet M, Spealman RD, Meltzer PC, George SR, O'Dowd BF, Bonab AA, Livni E, Fischman AJ; Fahey; Miller; de la Garza; Goulet; Spealman; Meltzer; George; O'Dowd; Bonab; Livni; Fischman. Non-amine-based dopamine transporter (reuptake) inhibitors retain properties of amine-based progenitors. Eur. J. Pharmacol. 2003, 479 (1–3): 41–51. PMID 14612136. doi:10.1016/j.ejphar.2003.08.055.

psychcentral.com

John M. Grohol. Top 25 Psychiatric Medication Prescriptions for 2013. Psych Central. 2014 [3 April 2015]. （原始内容存档于2015-03-31）.

springer.com

link.springer.com

Ciraulo, DA; Shader, RI (编). Pharmacotherapy of Depression. SpringerLink 2nd (New York, NY: Humana Press). 2011 [2015-10-04]. ISBN 978-1-60327-434-0. doi:10.1007/978-1-60327-435-7. （原始内容存档于2021-02-25）.

washingtonpost.com

Cipriani A, Furukawa TA, Salanti G, Geddes JR, Higgins JP, Churchill R, Watanabe N, Nakagawa A, Omori IM, McGuire H, Tansella M, Barbui C; Furukawa; Salanti; Geddes; Higgins; Churchill; Watanabe; Nakagawa; Omori; McGuire; Tansella; Barbui. Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. The Lancet. 2009, 373 (9665): 746–758. PMID 19185342. doi:10.1016/S0140-6736(09)60046-5. 简明摘要 – The Washington Post (29 January 2009).

web.archive.org

drugs.com drugs.com international Sertraline （页面存档备份，存于互联网档案馆） Page accessed May 11, 2015
Sertraline FDA Label. http://www.fda.gov/ohrms/dockets/ac/04/briefing/4006b1_06_zoloft-label.pdf （页面存档备份，存于互联网档案馆）
John M. Grohol. Top 25 Psychiatric Medication Prescriptions for 2013. Psych Central. 2014 [3 April 2015]. （原始内容存档于2015-03-31）.
Sertraline hydrochloride. The American Society of Health-System Pharmacists. [3 April 2011]. （原始内容存档于2016-03-08）.
Math SB, Janardhan Reddy YC. Issues In The Pharmacological Treatment of Obsessive-Compulsive Disorder: First-Line Treatment Options for OCD. medscape.com. 19 July 2007 [28 July 2009]. （原始内容存档于2021-01-25）.
Hansen, Richard A.; Gaynes, Bradley N.; Gartlehner, Gerald; Moore, Charity G.; Tiwari, Ruchi; Lohr, Kathleen N. Efficacy and Tolerability of Second-Generation Antidepressants in Social Anxiety Disorder. International clinical psychopharmacology. 2008-05, 23 (3): 170–179 [2019-03-30]. ISSN 0268-1315. PMC 2657552 . PMID 18408531. doi:10.1097/YIC.0b013e3282f4224a. （原始内容存档于2022-05-04）.
Hansen, Richard A.; Gaynes, Bradley N.; Gartlehner, Gerald; Moore, Charity G.; Tiwari, Ruchi; Lohr, Kathleen N. Efficacy and Tolerability of Second-Generation Antidepressants in Social Anxiety Disorder. International clinical psychopharmacology. 2008-05, 23 (3): 170–179 [2019-03-30]. ISSN 0268-1315. PMC 2657552 . PMID 18408531. doi:10.1097/YIC.0b013e3282f4224a. （原始内容存档于2022-05-04）.
Walkup, John T.; Albano, Anne Marie; Piacentini, John; Birmaher, Boris; Compton, Scott N.; Sherrill, Joel T.; Ginsburg, Golda S.; Rynn, Moira A.; McCracken, James. Cognitive Behavioral Therapy, Sertraline, or a Combination in Childhood Anxiety. The New England journal of medicine. 2008-12-25, 359 (26): 2753–2766 [2019-03-30]. ISSN 0028-4793. PMC 2702984 . PMID 18974308. doi:10.1056/NEJMoa0804633. （原始内容存档于2022-06-22）.
Gale, Christopher K; Millichamp, Jane. Generalised anxiety disorder. BMJ Clinical Evidence. 2011-10-27, 2011 [2019-03-30]. ISSN 1752-8526. PMC 3275153 . PMID 22030083. （原始内容存档于2022-05-09）.
Levenson M, Holland C. Antidepressants and Suicidality in Adults: Statistical Evaluation. (Presentation at Psychopharmacologic Drugs Advisory Committee; December 13, 2006). FDA. [11 July 2008]. （原始内容存档于2017-05-17）.
Stone MB, Jones ML. Clinical review: relationship between antidepressant drugs and suicidality in adults (PDF). Overview for December 13 Meeting of Psychopharmacologic Drugs Advisory Committee (PDAC). FDA: 11–74. 17 November 2006 [11 July 2008]. （原始内容存档 (PDF)于2007-03-16）.
Levenson M, Holland C. Statistical Evaluation of Suicidality in Adults Treated with Antidepressants (PDF). Overview for December 13 Meeting of Psychopharmacologic Drugs Advisory Committee (PDAC). FDA: 75–140. 17 November 2006 [11 July 2008]. （原始内容存档 (PDF)于2007-03-16）.
存档副本 (PDF). [2015-09-03]. （原始内容 (PDF)存档于2020-09-20）.
Ciraulo, DA; Shader, RI (编). Pharmacotherapy of Depression. SpringerLink 2nd (New York, NY: Humana Press). 2011 [2015-10-04]. ISBN 978-1-60327-434-0. doi:10.1007/978-1-60327-435-7. （原始内容存档于2021-02-25）.

webcitation.org

Blier P, Habib R, Flament MF; Habib; Flament. Pharmacotherapies in the management of obsessive-compulsive disorder (PDF). Can J Psychiatry. 2006, 51 (7): 417–30. PMID 16838823. （原始内容 (PDF)存档于2010-02-04）.

worldcat.org

Hansen, Richard A.; Gaynes, Bradley N.; Gartlehner, Gerald; Moore, Charity G.; Tiwari, Ruchi; Lohr, Kathleen N. Efficacy and Tolerability of Second-Generation Antidepressants in Social Anxiety Disorder. International clinical psychopharmacology. 2008-05, 23 (3): 170–179 [2019-03-30]. ISSN 0268-1315. PMC 2657552 . PMID 18408531. doi:10.1097/YIC.0b013e3282f4224a. （原始内容存档于2022-05-04）.
Hansen, Richard A.; Gaynes, Bradley N.; Gartlehner, Gerald; Moore, Charity G.; Tiwari, Ruchi; Lohr, Kathleen N. Efficacy and Tolerability of Second-Generation Antidepressants in Social Anxiety Disorder. International clinical psychopharmacology. 2008-05, 23 (3): 170–179 [2019-03-30]. ISSN 0268-1315. PMC 2657552 . PMID 18408531. doi:10.1097/YIC.0b013e3282f4224a. （原始内容存档于2022-05-04）.
Walkup, John T.; Albano, Anne Marie; Piacentini, John; Birmaher, Boris; Compton, Scott N.; Sherrill, Joel T.; Ginsburg, Golda S.; Rynn, Moira A.; McCracken, James. Cognitive Behavioral Therapy, Sertraline, or a Combination in Childhood Anxiety. The New England journal of medicine. 2008-12-25, 359 (26): 2753–2766 [2019-03-30]. ISSN 0028-4793. PMC 2702984 . PMID 18974308. doi:10.1056/NEJMoa0804633. （原始内容存档于2022-06-22）.
Gale, Christopher K; Millichamp, Jane. Generalised anxiety disorder. BMJ Clinical Evidence. 2011-10-27, 2011 [2019-03-30]. ISSN 1752-8526. PMC 3275153 . PMID 22030083. （原始内容存档于2022-05-09）.